Literature DB >> 30155967

Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis.

Elisabet Westerberg1, Anne-Marie Landtblom2, Anna Rostedt Punga1.   

Abstract

PURPOSE: To evaluate disease-specific differences between Myasthenia Gravis (MG) subgroups and compare patterns of lifestyle between MG patients and population controls.
METHODS: All MG patients (n = 70) in Jönköping County, Sweden, were invited to answer a disease-specific questionnaire, containing questions about disease-specific data, lifestyle, comorbidity, and mental fatigue. The patients were clinically evaluated. Four hundred age- and gender-matched population controls were invited to answer the nondisease-specific part of the questionnaire. Disease-specific issues were compared between MG subgroups. Lifestyle-related factors and concomitant conditions were compared to the population controls.
RESULTS: Forty MG patients and 188 population controls participated in the study. In the late-onset MG (LOMG; N = 18) subgroup, the male predominance was higher than previously reported. In the early-onset MG (EOMG; N = 17) subgroup, time to diagnosis was longer, fatigue was higher, and bulbar weakness was the dominant symptom (65%). Compared to their matched population controls, LOMG patients were more obese (OR = 13.7, P = 0.015), ate less fish (OR = 4.1, P = 0.012), tended to smoke more (OR = 4.1, P = 0.086), and tended to be employed as manual laborers more often (OR = 2.82, P = 0.083). Mental health problems and sickness benefits were more common among MG patients than in controls, and MG patients were less regularly doing focused physical activity.
CONCLUSIONS: It is important to consider disease-specific differences when tailoring the management of individual MG patients. There is a need for improved knowledge on how to apply primary and secondary prevention measures to lifestyle disorders in MG patients without risk of deterioration.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MG subgroups; Myasthenia Gravis; early-onset MG; environmental factors; fatigue; late-onset MG; lifestyle

Mesh:

Year:  2018        PMID: 30155967     DOI: 10.1111/ane.13017

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Association of Smoking and Generalized Manifestations of Myasthenia Gravis.

Authors:  Yusei Miyazaki; Masaaki Niino; Ken Sakushima; Eri Takahashi; Ryoji Naganuma; Itaru Amino; Sachiko Akimoto; Naoya Minami; Ichiro Yabe; Seiji Kikuchi
Journal:  Intern Med       Date:  2021-11-06       Impact factor: 1.282

2.  Outcome measures and treatment effectiveness in late onset myasthenia gravis.

Authors:  Francesca Pasqualin; Silvia V Guidoni; Mario Ermani; Elena Pegoraro; Domenico M Bonifati
Journal:  Neurol Res Pract       Date:  2020-10-30

3.  Epidemiology of Myasthenia Gravis in Sweden 2006-2016.

Authors:  Elisabet Westerberg; Anna Rostedt Punga
Journal:  Brain Behav       Date:  2020-09-01       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.